Talaris Therapeutics Stock Net Income
| TALSDelisted Stock | USD 2.98 0.10 3.25% |
Talaris Therapeutics fundamentals help investors to digest information that contributes to Talaris Therapeutics' financial success or failures. It also enables traders to predict the movement of Talaris Stock. The fundamental analysis module provides a way to measure Talaris Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Talaris Therapeutics stock.
Talaris |
Talaris Therapeutics Company Net Income Analysis
Talaris Therapeutics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Talaris Therapeutics Net Income | (73.89 M) |
Most of Talaris Therapeutics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Talaris Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Talaris Therapeutics reported net income of (73.89 Million). This is 121.65% lower than that of the Biotechnology sector and 205.49% lower than that of the Health Care industry. The net income for all United States stocks is 112.94% higher than that of the company.
Talaris Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Talaris Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Talaris Therapeutics could also be used in its relative valuation, which is a method of valuing Talaris Therapeutics by comparing valuation metrics of similar companies.Talaris Therapeutics is currently under evaluation in net income category among its peers.
Talaris Fundamentals
| Return On Equity | -0.42 | |||
| Return On Asset | -0.23 | |||
| Current Valuation | (28.92 M) | |||
| Shares Outstanding | 42.81 M | |||
| Shares Owned By Insiders | 11.90 % | |||
| Shares Owned By Institutions | 77.67 % | |||
| Number Of Shares Shorted | 340.1 K | |||
| Price To Book | 0.28 X | |||
| EBITDA | (74.31 M) | |||
| Net Income | (73.89 M) | |||
| Cash And Equivalents | 207.11 M | |||
| Cash Per Share | 4.97 X | |||
| Total Debt | 2.88 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 28.92 X | |||
| Book Value Per Share | 3.49 X | |||
| Cash Flow From Operations | (60.86 M) | |||
| Short Ratio | 4.01 X | |||
| Earnings Per Share | (1.97) X | |||
| Target Price | 20.0 | |||
| Number Of Employees | 84 | |||
| Beta | 2.18 | |||
| Market Capitalization | 125.73 M | |||
| Total Asset | 193.72 M | |||
| Retained Earnings | (164.74 M) | |||
| Working Capital | 174.15 M | |||
| Z Score | 24.78 | |||
| Net Asset | 193.72 M |
About Talaris Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Talaris Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Talaris Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Talaris Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Talaris Stock
If you are still planning to invest in Talaris Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talaris Therapeutics' history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |